Literature DB >> 34499590

Insulin Resistance Is Associated with Right Ventricular Dysfunction.

Jeff Min1, Mary E Putt2, Wei Yang2, Nadine Al-Naamani1, Alain G Bertoni3, Joao A C Lima4, R Graham Barr5, Lauren Beussink-Nelson6, Sanjiv J Shah6, Steven M Kawut1, Benjamin H Freed6.   

Abstract

Rationale: The effect of insulin resistance on left ventricular function is well documented; however, less is known regarding its effect on the right ventricle (RV).
Objectives: To evaluate the association between insulin resistance and RV function by echocardiography in a cohort of adults without baseline cardiovascular disease.
Methods: We performed a retrospective cohort study in the MESA (Multi-Ethnic Study of Atherosclerosis). Linear regression was used to examine the association between overall insulin resistance measured by the mean triglyceride (TG) to high-density lipoprotein (HDL) cholesterol ratio (TG:HDL) and change in TG:HDL over time for each participant with echocardiographic RV function. Logistic regression was used to calculate the odds ratios (ORs) of RV systolic and diastolic dysfunction.
Results: Among 3,032 participants, higher mean TG:HDL was associated with lower (worse) absolute RV longitudinal strain (β, -0.38; 95% confidence interval [CI], -0.64 to -0.13; P < 0.01), tricuspid annular plane systolic excursion (β, -0.05; 95% CI, -0.07 to -0.04; P < 0.001), and higher odds of abnormal RV strain (OR, 1.26; 95% CI, 1.08 to 1.47; P < 0.01) and abnormal tricuspid annular plane systolic excursion (OR, 1.31; 95% CI, 1.14 to 1.51; P < 0.001). TG:HDL was also associated with lower ratio of tricuspid early to late ventricular filling velocities (E/A) (β, -0.03; 95% CI, -0.04 to -0.01; P < 0.01), higher ratio of early diastolic tricuspid inflow to tricuspid lateral annular velocity (E/e') (β, 0.15; 95% CI, 0.07 to 0.23; P < 0.001), and higher odds of graded RV diastolic dysfunction (OR, 1.19; 95% CI, 1.03 to 1.39; P < 0.05). These associations remained following multivariable adjustment. Conclusions: Insulin resistance was associated with decreased RV systolic and diastolic function after adjusting for alternative causes of RV dysfunction, suggesting that insulin-resistant individuals are at risk for early RV dysfunction, even in the absence of cardiovascular disease.

Entities:  

Keywords:  echocardiography; high-density lipoprotein cholesterol; insulin resistance; right ventricle; triglyceride

Mesh:

Year:  2022        PMID: 34499590      PMCID: PMC8996272          DOI: 10.1513/AnnalsATS.202107-766OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  51 in total

1.  The impact of ageing on right ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study.

Authors:  Pasquale Innelli; Roberta Esposito; Marinella Olibet; Stefano Nistri; Maurizio Galderisi
Journal:  Eur J Echocardiogr       Date:  2008-12-10

2.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

Review 3.  Right ventricular dysfunction and remodeling in diabetic cardiomyopathy.

Authors:  Yin Kang; Sheng Wang; Jiapeng Huang; Lu Cai; Bradley B Keller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-09       Impact factor: 4.733

4.  Impact of diabetes in patients with pulmonary hypertension.

Authors:  Abraham D Abernethy; Kathryn Stackhouse; Stephen Hart; Ganesh Devendra; Thomas M Bashore; Raed Dweik; Richard A Krasuski
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

5.  Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study.

Authors:  Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

6.  Multiple imputation using chained equations: Issues and guidance for practice.

Authors:  Ian R White; Patrick Royston; Angela M Wood
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

7.  Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.

Authors:  Levi Benson; Evan L Brittain; Meredith E Pugh; Eric D Austin; Kelly Fox; Lisa Wheeler; Ivan M Robbins; Anna R Hemnes
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

8.  Human PAH is characterized by a pattern of lipid-related insulin resistance.

Authors:  Anna R Hemnes; J Matthew Luther; Christopher J Rhodes; Jason P Burgess; James Carlson; Run Fan; Joshua P Fessel; Niki Fortune; Robert E Gerszten; Stephen J Halliday; Rezzan Hekmat; Luke Howard; John H Newman; Kevin D Niswender; Meredith E Pugh; Ivan M Robbins; Quanhu Sheng; Cyndya A Shibao; Yu Shyr; Susan Sumner; Megha Talati; John Wharton; Martin R Wilkins; Fei Ye; Chang Yu; James West; Evan L Brittain
Journal:  JCI Insight       Date:  2019-01-10

9.  Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation.

Authors:  Evan L Brittain; Chike Nwabuo; Meng Xu; Deepak K Gupta; Anna R Hemnes; Henrique T Moreira; Henrique Doria De Vasconcellos; James G Terry; Jeffrey J Carr; Joao A C Lima
Journal:  J Am Heart Assoc       Date:  2017-03-30       Impact factor: 5.501

10.  Subclinical alterations in left ventricular structure and function according to obesity and metabolic health status.

Authors:  Hyun-Jung Lee; Hack-Lyoung Kim; Woo-Hyun Lim; Jae-Bin Seo; Sang-Hyun Kim; Joo-Hee Zo; Myung-A Kim
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.